VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CLS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CLSCelestica Inc.
$387.32$44.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCLSFinancials

Celestica Inc. (CLS) Income Statement

29Y historyFree accessUpdated daily

Revenue surged 62.4% YoY to $4.7B in 2026Q2 with gross margin expanding to 12.3% from 10.6% a year earlier, though EPS of $3.17 missed consensus by $0.14.

Income StatementBalance SheetCash FlowRatios

CLS Income Statement

Annual statement

CLS Income Statement

Celestica Inc. (CLS) annual income statement — 29-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97
Sales/Revenue15.62B12.61B9.65B7.96B7.25B5.63B5.75B5.89B6.63B6.14B6.05B5.64B5.63B5.8B6.51B7.21B6.53B6.09B7.68B8.07B8.81B8.47B8.84B6.74B8.27B10B9.75B5.3B3.25B2B
Revenue Growth %47.49%30.71%21.17%9.81%28.67%-1.97%-2.38%-11.23%7.99%1.59%7.22%0.14%-2.84%-10.93%-9.79%10.53%7.12%-20.66%-4.86%-8.41%4.02%-4.17%31.25%-18.57%-17.32%2.59%84.1%63.03%62.09%-
Cost of Goods Sold13.81B11.13B8.61B7.21B6.6B5.15B5.31B5.5B6.2B5.72B5.62B5.25B5.23B5.41B6.07B6.72B6.08B5.66B7.15B7.65B8.36B7.99B8.43B6.48B7.72B9.29B9.06B4.84B2.98B1.84B
COGS % of Revenue-88.31%89.28%90.53%91.04%91.36%92.39%93.47%93.51%93.19%92.9%93.06%92.8%93.28%93.26%93.23%93.19%92.95%93.08%94.77%94.87%94.32%95.39%96.14%93.29%92.88%92.95%91.44%91.63%91.96%
Gross Profit1.81B1.47B1.03B754.1M649.7M487M437.6M384.7M430.5M418.5M429.6M391.1M405.4M389.5M438.4M488.6M444.1M429.8M531.1M422.4M451.8M481.1M407.9M260.1M555.1M712.5M688M453.5M272.1M161.22M
Gross Margin %11.59%11.69%10.72%9.47%8.96%8.64%7.61%6.53%6.49%6.81%7.1%6.94%7.2%6.72%6.74%6.77%6.8%7.05%6.92%5.23%5.13%5.68%4.61%3.86%6.71%7.12%7.05%8.56%8.37%8.04%
Gross Profit Growth %-42.58%37.08%16.07%33.41%11.29%13.75%-10.64%2.87%-2.58%9.84%-3.53%4.08%-11.15%-10.27%10.02%3.33%-19.07%25.73%-6.51%-6.09%17.95%56.82%-53.14%-22.09%3.56%51.71%66.67%68.78%-
Operating Expenses540.71M384.72M434.4M415.8M360.4M319.3M309.7M235.4M324.2M275.3M270.9M275.7M277.7M255.9M323M287.2M317.8M429.8M531.1M316.5M313.5M325.9M523M416.3M800.9M762.3M414.99M328.7M217.5M105.24M
OpEx % of Revenue-3.05%4.5%5.22%4.97%5.67%5.39%4%4.89%4.48%4.48%4.89%4.93%4.42%4.96%3.98%4.87%7.05%6.92%3.92%3.56%3.85%5.92%6.18%9.68%7.62%4.26%6.21%6.69%5.25%
Selling, General & Admin285.08M264.45M293.5M303.2M267.3M245.1M230.7M231.4M219M205.1M211.1M207.5M210.3M222.3M237M253.4M252.1M244.5M292M295.1M285.6M296.9M331.6M273.8M298.5M341.4M326.05M202.2M130.6M68.2M
SG&A % of Revenue-2.1%3.04%3.81%3.69%4.35%4.01%3.93%3.3%3.34%3.49%3.68%3.73%3.84%3.64%3.51%3.86%4.01%3.8%3.66%3.24%3.5%3.75%4.07%3.61%3.41%3.34%3.82%4.02%3.4%
Research & Development154.56M120.27M78M60.9M46.3M38.4M29.9M28.4M28.8M26.2M24.9M23.2M19.7M17.4M15.2M13.8M000000024M000000
R&D % of Revenue-0.95%0.81%0.77%0.64%0.68%0.52%0.48%0.43%0.43%0.41%0.41%0.35%0.3%0.23%0.19%-------0.36%------
Other Operating Expenses3M062.9M51.7M46.8M35.8M49.1M-24.4M76.4M44M34.9M45M47.7M16.2M70.8M20M65.7M185.3M239.1M21.4M27.9M29M191.4M118.5M502.4M420.9M88.94M126.5M86.9M37.04M
Operating Income1.27B1.09B599.3M338.3M289.3M167.7M127.9M149.3M106.3M143.2M158.7M115.4M127.7M133.6M115.4M201.4M126.3M207.5M221.6M105.9M138.3M155.2M-115.1M-156.2M-245.8M-49.8M273.01M124.8M54.6M55.97M
Operating Margin %8.13%8.64%6.21%4.25%3.99%2.98%2.23%2.54%1.6%2.33%2.62%2.05%2.27%2.31%1.77%2.79%1.94%3.41%2.89%1.31%1.57%1.83%-1.3%-2.32%-2.97%-0.5%2.8%2.36%1.68%2.79%
Operating Income Growth %-81.73%77.15%16.94%72.51%31.12%-14.33%40.45%-25.77%-9.77%37.52%-9.63%-4.42%15.77%-42.7%59.46%-39.13%-6.36%109.25%-23.43%-10.89%234.84%26.31%36.45%-393.57%-118.24%118.76%128.57%-2.46%-
EBITDA1.41B1.27B751.2M469.1M405.2M294M252.6M284.7M195.4M219.7M234.3M183.7M196.4M205.3M197.1M278.6M213.3M307.9M330.8M236.7M272.5M307.9M92.6M66.5M65.6M269.7M485.51M251.3M141.5M93.01M
EBITDA Margin %9.01%10.06%7.79%5.89%5.59%5.22%4.39%4.83%2.95%3.58%3.87%3.26%3.49%3.54%3.03%3.86%3.27%5.05%4.31%2.93%3.09%3.63%1.05%0.99%0.79%2.7%4.98%4.74%4.35%4.64%
EBITDA Growth %60.03%68.79%60.14%15.77%37.82%16.39%-11.28%45.7%-11.06%-6.23%27.54%-6.47%-4.34%4.16%-29.25%30.61%-30.72%-6.92%39.76%-13.14%-11.5%232.51%39.25%1.37%-75.68%-44.45%93.2%77.6%52.13%-
D&A (Non-Cash Add-back)132.96M178.78M151.9M130.8M115.9M126.3M124.7M135.4M89.1M76.5M75.6M68.3M68.7M71.7M81.7M77.2M87M100.4M109.2M130.8M134.2M152.7M207.7M222.7M311.4M319.5M212.5M126.5M86.9M37.04M
EBIT1.37B1.05B584.3M384.9M290.8M167.42M127.9M149.3M106.3M143.2M173M115.4M127.7M133.6M115.4M201.4M126.3M95.7M-657.7M106M139.2M155.8M41.7M-62.2M160.7M-27M273.01M124.8M54.6M55.97M
Net Interest Income-16.45M-53.52M-52.1M-78.9M-51.7M-31.42M-37.7M-50.65M-25.6M-10.1M4.3M-6.3M-3.1M-2.9M-3.5M-5.4M-6.9M-35M-42.5M00000000000
Interest Income46.2M00000000014.3M000000300K15.3M00000000000
Interest Expense62.65M53.52M52.1M78.9M51.7M31.42M37.7M50.65M24.4M10.1M10M6.3M3.1M2.9M3.5M5.4M6.9M35.3M57.8M00000000000
Other Income/Expense42.54M-88.73M-67.1M-32.3M-50.2M-31.7M-37.7M-49.5M-24.4M-10.1M4.3M-6.3M-3.1M-2.9M-3.5M-5.4M-6.9M-147.1M-937.1M-98.8M-274.4M-180.7M-486.8M-77M-307.9M7.9M2.88M-20.3M-105.1M-60.73M
Pretax Income1.31B1B532.2M306M239.1M136M90.2M99.8M81.9M133.1M163M109.1M124.6M130.7M111.9M196M119.4M60.4M-715.5M7.1M-136.1M-25.5M-601.9M-233.2M-553.7M-41.9M275.89M104.5M-50.5M-4.75M
Pretax Margin %8.4%7.93%5.52%3.84%3.3%2.41%1.57%1.69%1.23%2.17%2.7%1.93%2.21%2.25%1.72%2.72%1.83%0.99%-9.32%0.09%-1.54%-0.3%-6.81%-3.46%-6.69%-0.42%2.83%1.97%-1.55%-0.24%
Income Tax193.74M153.34M104.2M61.6M59M32.1M29.6M29.5M-17M27.6M24.7M42.2M16.4M12.7M-5.8M3.7M18.2M5.4M5M20.8M14.5M21.3M252.2M33.5M-98.3M-2.1M69.21M36.1M-2M2.17M
Effective Tax Rate %14.77%15.33%19.58%20.13%24.68%23.6%32.82%29.56%-20.76%20.74%15.15%38.68%13.16%9.72%-5.18%1.89%15.24%8.94%-0.7%292.96%-10.65%-83.53%-41.9%-14.37%17.75%5.01%25.09%34.55%3.96%-45.59%
Net Income1.12B847.07M428M244.4M180.1M103.9M60.6M70.3M98.9M105.5M138.3M66.9M108.2M118M117.7M192.3M101.2M55M-720.5M-13.7M-150.6M-46.8M-854.1M-266.7M-455.4M-39.8M206.68M68.4M-48.5M-6.92M
Net Margin %7.16%6.72%4.44%3.07%2.48%1.84%1.05%1.19%1.49%1.72%2.29%1.19%1.92%2.04%1.81%2.67%1.55%0.9%-9.38%-0.17%-1.71%-0.55%-9.66%-3.96%-5.51%-0.4%2.12%1.29%-1.49%-0.35%
Net Income Growth %113.31%97.91%75.12%35.7%73.34%71.45%-13.8%-28.92%-6.26%-23.72%106.73%-38.17%-8.31%0.25%-38.79%90.02%84%107.63%-5159.12%90.9%-221.79%94.52%-220.25%41.44%-1044.22%-119.26%202.16%241.03%-601.05%-
Net Income (Continuing)1.12B847.07M428M244.4M180.1M103.9M60.6M70.3M98.9M105.5M138.3M66.9M108.2M118M117.7M192.3M101.2M55M-720.5M-13.7M-150.6M-46.8M-854.1M-266.7M-455.4M-39.8M206.68M68.4M-48.5M-6.92M
Discontinued Operations000000000000000000000000000000
Minority Interest000000000000000000000000000000
EPS (Diluted)9.627.293.612.031.460.820.470.530.700.720.950.420.600.640.560.890.350.24-3.14-0.06-0.66-0.21-3.85-1.23-1.98-0.190.990.40-0.26-0.05
EPS Growth %114.48%101.94%77.83%39.04%78.05%74.47%-11.32%-24.29%-2.78%-24.21%126.19%-30%-6.25%14.29%-37.08%154.29%45.83%107.64%-5142.07%90.92%-214.29%94.55%-213.01%37.88%-942.11%-119.19%147.5%253.85%-396.18%-
EPS (Basic)-7.353.622.041.460.820.470.540.710.730.960.430.610.640.560.900.350.24-3.14-0.06-0.66-0.21-3.85-1.23-1.98-0.191.010.41-0.26-0.05
Diluted Shares Outstanding116.2M116.2M118.7M120.3M123.6M126.7M129.1M131.8M140.6M145.2M143.9M157.9M180.4M185.4M210.5M218.3M230.1M230.9M229.3M228.9M227.2M226.2M222.1M216.83M229.8M213.9M217.91M178.43M183.02M132M
Basic Shares Outstanding115M115.3M118.1M120.1M123.5M126.7M129.1M131M139.4M143.1M141.8M155.8M178.4M183.4M208.6M216.3M227.8M229.5M229.3M228.9M227.2M226.2M222.1M216.83M229.8M213.9M199.79M167.19M183.02M132M
Dividend Payout Ratio------------------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrong
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Hyperscaler concentration and margin ceiling

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Hyperscaler-Driven Revenue Acceleration

Revenue surged 62.4% YoY in 2026Q2 to $4.7B, per recent financial statements, marking the fourth consecutive quarter of accelerating growth, driven by CCS segment demand for AI infrastructure.

The sequential revenue increase from $4.0B in 2026Q1 to $4.7B in 2026Q2 represents a 17.5% QoQ jump, far outpacing the prior year's growth rate of 21%. This acceleration appears tied to hyperscaler capital expenditure cycles, with the company's JDM model capturing higher-value design work. However, the implied moderation in forward guidance (Q3 revenue guided to $5.25B-$5.55B, implying ~13% QoQ growth) suggests the pace may be peaking, warranting monitoring for a potential normalization in ordering patterns.

Gross Margin Expansion at EMS High End

Gross margin reached 12.3% in 2026Q2, up from 10.6% a year earlier, as reported in the income statement, positioning Celestica above peers like Jabil (8.9%) and Flex (9.2%).

The 170 basis point YoY gross margin improvement indicates a favorable mix shift toward higher-complexity JDM programs and away from commoditized assembly. This structural uplift appears sustainable given the company's specialization in 800G networking and AI compute platforms, which command premium pricing. However, the sequential dip from 12.8% in 2025Q2 to 12.3% in 2026Q2 hints at potential margin ceiling pressures as revenue scales, possibly due to customer concentration or component pass-through dynamics.

Operating Leverage Amplifies Profit Growth

Operating income grew 68% YoY in 2026Q2 to $458.3M, outpacing revenue growth of 62.4%, per the latest quarterly report, demonstrating strong operating leverage from SG&A efficiency.

SG&A as a percentage of revenue fell to 1.2% in 2026Q2 from 2.0% in 2025Q2, while R&D remained relatively stable at ~1% of revenue. This suggests management is scaling the business without proportionate overhead increases, a hallmark of the JDM model's efficiency. The operating margin of 9.8% in 2026Q2 is a record high, up from 9.4% in the prior year, indicating that incremental revenue is flowing through to profit at an accelerating rate. Investors should monitor whether this leverage persists as growth moderates.

EPS Quality Tempered by Consensus Miss

Diluted EPS of $3.17 in 2026Q2 beat the company's guidance but missed consensus estimates of $3.03, according to recent earnings reports, despite a 74.2% YoY increase.

The EPS miss versus consensus, despite a revenue beat, suggests that sell-side expectations had priced in even more aggressive margin expansion. Stock-based compensation of $19.3M in 2026Q2, while modest relative to net income of $368.8M, adds a small drag on reported earnings. The effective tax rate appears normalized, with net margin of 7.8% closely tracking operating margin, indicating limited non-operating distortions. However, the divergence between reported EPS and consensus warrants scrutiny of the quality of the beat, particularly if it was driven by one-time items.

COGS Dominates but R&D Investment Rises

COGS accounted for 87.7% of revenue in 2026Q2, per the income statement, reflecting the pass-through nature of component costs, while R&D spending grew 36% YoY to $46.3M.

The high COGS ratio is typical for EMS providers, but Celestica's gross margin of 12.3% indicates it is capturing more value than peers. R&D investment has increased from $34.0M in 2025Q2 to $46.3M in 2026Q2, signaling a commitment to maintaining its design-in advantage in AI infrastructure. SG&A, however, has been volatile, with 2026Q1 showing $117.4M versus $58.1M in 2026Q2, suggesting potential timing of expenses or one-time charges. Management's expense discipline appears strong, but the R&D ramp could pressure margins if revenue growth decelerates.

Margin Ceiling and Customer Concentration Risks

Despite record margins, the 2026Q2 EPS miss versus consensus and sequential gross margin decline from 12.8% to 12.3% suggest the market may be overestimating the durability of Celestica's profitability.

Short-sellers could argue that the company's growth is heavily dependent on a few hyperscale customers, with top-10 customer concentration increasing, creating a cliff risk if any single customer shifts its hardware strategy. The gross margin plateau, despite revenue scaling, may indicate that the JDM premium is being competed away or that component cost pass-throughs are becoming less favorable. Additionally, the elevated capital expenditure requirements to support AI capacity could pressure free cash flow conversion, even as the balance sheet remains underlevered. If hyperscaler spending normalizes, the operating leverage could reverse, compressing margins from current highs.

CLS — Frequently Asked Questions

Quick answers to the most common questions about buying CLS stock.

What was Celestica Inc.'s (CLS) revenue in 2025?

For fiscal year 2025, Celestica Inc. (CLS) reported total revenue of $12.61B. This represents a 528.9% increase compared to $2.00B in 1997.

Is Celestica Inc. (CLS) profitable?

Celestica Inc. (CLS) is profitable, generating $847.1M in net income for the fiscal year ending 2025 with a net profit margin of 6.7%.

What is Celestica Inc.'s operating profit margin?

Celestica Inc. (CLS) reported an operating income of $1.09B, resulting in an operating profit margin of 8.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Celestica Inc.'s gross profit and gross margin?

Celestica Inc. (CLS) generated $1.47B in gross profit for the year, representing a gross profit margin of 11.7%. This demonstrates the company's core pricing power and production efficiency.